Camstent Case Study

Urinary tract infections (UTIs), as a result of wearing a catheter, pose significant challenges in healthcare, leading to patient discomfort, prolonged hospital stays, increased antibiotic usage, and elevated healthcare costs. Addressing these issues, Camstent and Pennine Healthcare have collaborated to provide an innovative solution that enhances patient care and safety.

Speak To An Expert

Patient Requirements and Needs

Patients requiring catheterisation often face the risk of bacterial infections due to biofilm formation on catheter surfaces. These biofilms serve as protective environments for bacteria, making infections difficult to treat and leading to complications such as:

• Increased discomfort and pain
• Extended hospitalisation periods
• Higher dependency on antibiotics, contributing to antimicrobial resistance
• Escalated medical expenses

Therefore, there is a critical need for catheters that minimise bacterial adhesion and subsequent infection risks.

Camstent and Pennine Healthcare’s Solution

Camstent has developed the BACTERIA-PHOBIC® Coated Foley Catheter, featuring a proprietary non-eluting polymer coating that repels bacteria and prevents biofilm formation. This non-pharmacologic approach ensures bacteria are deterred from adhering to the catheter surface, thereby reducing infection rates without promoting antibiotic resistance.

Pennine Healthcare, a leading UK-based manufacturer and distributor of single-use sterile medical devices, partners with Camstent to supply these innovative catheters across the UK. Leveraging their extensive experience and commitment to quality, Pennine Healthcare ensures that healthcare providers have access to these advanced catheters, facilitating improved patient outcomes.

Issues Addressed by the Collaboration

The partnership between Camstent and Pennine Healthcare effectively tackles several critical issues:

• Reduction of Infections: The BACTERIA-PHOBIC® coating significantly lowers the incidence of UTi’s by preventing bacterial adhesion and biofilm development.
• Combatting Antimicrobial Resistance: By employing a non-pharmacologic method that repels rather than kills bacteria, the risk of bacterial adhesion and ensuing infection is minimized.
• Enhanced Patient Comfort: The catheter’s silky, smooth, and micro-thin coating reduces friction, thereby decreasing discomfort during insertion and use.
• Cost Efficiency: Lower infection rates can lead to reduced hospital stays and decreased reliance on antibiotics, resulting in potential cost savings for healthcare systems.

Advantages of Working with Camstent and Pennine Healthcare

The collaboration between Camstent and Pennine Healthcare offers several benefits:

• Innovative Technology: Camstent’s cutting-edge BACTERIA-PHOBIC® coating represents a significant advancement in reducing UTI’s and the use of antibiotics.
• Quality Assurance: Pennine Healthcare’s adherence to stringent quality standards ensures that the catheters meet all necessary safety and efficacy requirements, providing healthcare professionals with reliable and effective tools.
• Comprehensive Support: Pennine Healthcare’s extensive distribution network and customer support services ensure that healthcare providers receive timely assistance and access to necessary resources.
• Commitment to Patient Care: Both companies prioritise patient safety and comfort, striving to deliver products that enhance the overall healthcare experience.

In summary, the partnership between Camstent and Pennine Healthcare addresses critical patient needs by providing an innovative catheter solution that reduces infection risks, enhances comfort, and contributes to the fight against antimicrobial resistance. This collaboration exemplifies how strategic partnerships in the medical field can lead to significant improvements in patient care and healthcare efficiency.